comparemela.com

Latest Breaking News On - Hillhouse capital group - Page 6 : comparemela.com

Sequoia China joins US-based $155m ArriVent Biopharma s Series B round

The firm has so far raised a total of $300 million.

Zhang leiArrivent biopharmaAllist pharmaceuticalsHillhouse capital groupUnicorn capital partnersPennsylvania based arrivent biopharmaSofinnova investmentsGeneral catalystCatalio capital managementShanghai healthcare capitalSequoia chinaTerra magnum capital partnersUnicorn capital partners limitedInfinitum asset managementLilly asia venturesOctagon capital advisors

Nasdaq-listed Hywin mulls secondary listing in Hong Kong

Hywin raised $48m in a US initial public offering (IPO) in March 2021.

Hong kongHywin holdings ltdHillhouse capital groupNasdaq listed chinese

Elite American universities invest with Chinese firm tied to Uyghur genocide

Some of the largest and most competitive universities in the United States have invested massive amounts in cash with a shady private equity firm linked to the Chinese government's genocide of Uyghur Muslims, records show.

United statesZhang leiYale universitySan franciscoNational university of singaporeSingapore generalNew havenMichael cunninghamDonald trumpDustin carmackTung chee hwaDavid swensenUniversity of californiaCouncil on foreign relationsUniversity of texas systemIvy league

Alibaba faces pressure from Cohen to raise buyback program to $60 billion

Cohen, 37, has a net worth estimated at $2.5 billion. He made a splash in the investing world two years ago when he joined GameStop.

Dan loebRyan cohenBed bath beyondApple incHillhouse capital groupAlibaba groupWells fargoWall streetBed bathThird point

Monday Moves: 3 Philly biotech companies are starting 2023 with fresh funding

Plus, a potential rift in a merger deal for Carisma Therapeutics.

United statesMichael torokBradleyl radoffViela bioBing yaoMark kerschnerArrivent biopharmaAllist pharmaMike beyerCarisma therapeutics incIonis pharmaceuticals incHillhouse capital groupMoney movesVent biopharmaShanghai based allist pharmaBiz journal

vimarsana © 2020. All Rights Reserved.